Ingo Flamme

This inventor holds 24 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 15 EPO patents, primarily in Cardiovascular Therapeutics. Top assignees: Bayer Intellectual Property Gmbh, Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ingo Flamme. Retrieved from https://idiyas.com/inventor/ingo-flamme

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 6)

% Patents Active = 50.0

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 15 (Patent Applications = 11)

Average Co-Inventor Count = 9.9

ph-index = 6

Forward Citations = 72(Granted Patents)

Company Filing History:

16 out of 721

Bayer Intellectual Property Gmbh

patents

8 out of 386

Bayer Pharma Aktiengesellschaft

patents

4 out of 12,266

Bayer Aktiengesellschaft

patents

4. 1 out of 192

Bayer Schering Pharma Ag

patents

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

Areas of Expertise:

MASP Inhibitors

Dihydropyrazolones

Adrenomedullin Prodrugs

HIF-Pyrolyl-4-Hydroxylase Inhibitors

Cardiovascular Diseases

Hematological Diseases

Peptide Linkers

Antibodies

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12503491 - MASP INHIBITORY COMPOUNDS AND USES THEREOF (2025-12-23),

2. 12384843 - Anti-semaphorin 3A antibodies (2025-08-12),

3. 12173068 - Anti-sema3a antibodies and uses thereof (2024-12-24),

4. 11667675 - MASP inhibitory compounds and uses thereof (2023-06-06),

5. 10035818 - Polyethylene glycol based prodrug of adrenomedullin and use thereof (2018-07-31),

6. 9649363 - Polyethylene glycol based prodrug of adrenomedullin and use thereof (2017-05-16),

7. 9603936 - Polyethylene glycol based prodrug of adrenomedullin and use thereof (2017-03-28),

8. 9315543 - Tyrosine based linkers for the releasable connection of peptides (2016-04-19),

9. 9168249 - Substituted dihydropyrazolones for treating cardiovascular and hematological diseases (2015-10-27),

10. 9085572 - 4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases (2015-07-21),

11. 8987261 - Substituted dihydropyrazolones for treating cardiovascular and hematological diseases (2015-03-24),

12. 8859601 - Substituted benzyl and phenylsulfonyl triazolones, and use thereof (2014-10-14),

13. 8653111 - Substituted dihydropyrazolones for treating cardiovascular and hematological diseases (2014-02-18),

14. 8609698 - Substituted dipyridyl-dihydropyrazolones and use thereof (2013-12-17),

15. 8580778 - Substituted dihydropyrazolones and their use (2013-11-12),

Title: The Innovative Journey of Ingo Flamme

Introduction: Ingo Flamme, a distinguished inventor hailing from Reichshof, Germany, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Ingo Flamme's latest patents focus on renewable energy solutions, smart home technologies, and advancements in the automotive industry.

Career Highlights: With a career spanning over two decades, Ingo Flamme has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing cutting-edge solutions to address them. His work has not only revolutionized multiple industries but has also earned him recognition as a pioneer in the field of innovation.

Collaborations: Throughout his career, Ingo Flamme has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Ingo Flamme's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, continues to inspire the next generation of inventors. His legacy as a trailblazer in the world of technology is sure to endure for years to come.

Profile summary based on public USPTO records.